NewEdge Advisors’s Sanara MedTech SMTI Stock Holding History

NewEdge Advisors’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-758	Closed	-$17.9K	–	4416
2026 Q2	$17.9K	Hold	758	–	–	﹤0.01%	3389
2026 Q1	$13K	Sell	758 -9,631	-93%	-$198K	﹤0.01%	3325
2025 Q4	$243K	Buy	+10,389	New	+$268K	﹤0.01%	2462
2023 Q3	–	Sell	-73	Closed	-$2.93K	–	3638
2023 Q2	$2.93K	Buy	+73	New	+$2.99K	﹤0.01%	2979

Other funds holding SMTI

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Transmarket Holdings Chicago, Illinois $179M AUM 32.06% 1-Year Est. Return

ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $422M AUM 45.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 21.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

NewEdge Advisors's SMTI Position: Q3 2026 in Review

NewEdge Advisors sold out of Sanara MedTech (SMTI) in Q3 2026, closing a stake of 758 shares — an estimated $17.9K sold.

NewEdge Advisors first reported a position in SMTI in Q2 2023 and held it in 4 quarters. The position peaked at $243K in Q4 2025. 61 funds tracked by Wall St. Rank hold SMTI as of Q3 2026.

NewEdge Advisors reported no remaining Sanara MedTech position as of Q3 2026 after selling out during the quarter.
NewEdge Advisors sold 758 Sanara MedTech shares in Q3 2026, an estimated $17.9K.
NewEdge Advisors first reported a position in Sanara MedTech in Q2 2023 and held it in 4 quarters.
NewEdge Advisors's Sanara MedTech position peaked at $243K in Q4 2025.
61 funds tracked by Wall St. Rank held Sanara MedTech as of Q3 2026.

Based on NewEdge Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.